All posts by : Felistas

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases. Black women are twice as likely as white women to be diagnosed with TNBC and 28% more likely to die from it.

A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct retinal disorder in children following high fever illness. The study describes hyperacute outer retinal dysfunction (HORD), a condition marked by sudden bilateral vision loss, photoreceptor disruption, and variable recovery.

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, which are a type of white blood cell, play a role in the development of MS and are thus a target for therapies.

In a world first, researchers from Flinders University have applied advanced gene editing to explore how an enzyme, made famous in the COVID-19 pandemic, plays a pivotal role in the healthy development of the placenta during pregnancy.

Researchers have developed comfortable, washable “smart pajamas” that can monitor sleep disorders such as sleep apnea at home, without the need for sticky patches, cumbersome equipment or a visit to a specialist sleep clinic.

Heat stroke poses a significant health risk, especially during extreme temperature conditions. As global temperatures rise due to climate change, the frequency and severity of heat waves have increased, putting vulnerable populations at greater risk.

A University of Alabama at Birmingham Heersink School of Medicine-led study suggests that first-time transient ischemic attacks (TIA) are associated with long-term cognitive decline.

Researchers at The Wistar Institute’s HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the virus to persist. Wistar scientists have labeled this new approach “NuKES”: Natural Killer Enhancement Strategy.

Researchers from The University of Manchester—in collaboration with the Universities of Granada, Lund, and Oslo—have conducted the first-ever ethical analysis of artificial human DNA.

Maybe it’s a life hack or a liability, or a little of both. A surprising result in a new MIT study may suggest that people and animals alike share an inherent propensity to keep updating their approach to a task even when they have already learned how they should approach it and even if the deviations sometimes lead to unnecessary error.